Most cases of congenital adrenal hyperplasia, the inherited inability to synthesize cortisol, are caused by mutations in the steroid 21-hydroxylase gene (CYP21). Steroid 21-hydroxylase deficiency is unusual among genetic diseases in that -95% of the mutant alleles have apparently been generated by recombination between a normally active gene (CYP21) and a linked pseudogene (CYP21P). Approximately 20% of mutant alleles carry DNA deletions of 30 kb that have presumably been generated by unequal meiotic crossing-over, whereas 75% carry one or more mutations in CYP21 that are normally found in the CYP21P pseudogene. These latter mutations are termed "gene conversions," although the mechanism by which they are generated is not well understood. To assess the frequency at which these different recombination events occur, we have used PCR to detect de novo deletions and gene conversions in matched sperm and peripheral blood leukocyte DNA samples from normal individuals. Deletions with breakpoints in a 100-bp region in intron 2 and exon 3 were detected in speri DNA samples with frequencies of -1 in 105-106 genomes out were never detected in the matching leukocyte DNA. Gene conversions in the same region occur in -1 in 103-105 genomes in both sperm and leukocyte DNA. These data suggest that whereas deletions occur exclusively in meiosis, gene conversions occur during both meiosis and mitosis, or perhaps only during mitosis. Thus, gene conversions must occur by a mechanism distinct from unequal crossing-over.
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Congenital adrenal hyperplasia is an inherited disorder of cortisol biosynthesis. Although five different enzymes are required to synthesize cortisol in the adrenal cortex, steroid 21-hydroxylase deficiency accounts for >90% of congenital adrenal hyperplasia (1) . This defect is one of the most common inborn errors of metabolism in humans; the severe "classic" form of 21-hydroxylase deficiency occurs in 1 in 10,000-15,000 individuals, whereas a milder "nonclassic" form is found in up to 2-3% of several ethnic groups such as Ashkenazi (Eastern European) Jews (2) .
There are normally two 21-hydroxylase genes in humans: CYP21 is the functional gene whereas CYP21P is a pseudogene that carries small deletions, insertions, and point mutations that prevent synthesis of a functional enzyme. These genes are -98% identical in nucleotide sequence (3, 4) . Both are located within the HL,A major histocompatibility complex locus on chromosome 6p21.3, adjacent to and alternating with the C4A and C4B genes encoding the fourth component of the serum complement (5) .
Steroid 21-hydroxylase deficiency is unusual among genetic diseases in that -95% of mutant alleles have apparently been generated through intergenic recombination. Twenty percent of alleles have a 30-kb deletion including the 3' end of CYP21P, all of C4B, and the 5' end of CYP21 (6) . These chromosomes thus carry a single nonfunctional chimeric gene with 5' and 3' ends corresponding to CYP21P and CYP21, respectively. Presumably the normal tandem duplication of C4 and CYP21 is prone to misalignment during meiosis, leading to unequal crossing-over.
Approximately 75% of alleles have apparently been generated by another type of intergenic recombination. These chromosomes do not carry deletions, but instead CYP21 carries one or more deleterious mutations normally found in CYP21P (7) . These mutations are referred to as "gene conversions," although the mechanism by which they are generated is not well understood (8) .
The very high proportion of intergenic recombinations seen among 21-hydroxylase deficiency alleles suggests that these genes contain one or more "hotspots" for recombination. However, interpretation of allele frequencies is complicated by the presence of founder effects. For example, about half of deletions are associated with the rare extended HLA haplotype A3;Bw47;DR7 (6), whereas the majority of nonclassic alleles carry an apparent gene conversion, V281L, on the HLA haplotype B14;DRI (9) . Because gene conversions differ in the degree of enzymatic impairment they confer (10), it is possible that ascertainment biases also affect observed allele frequencies.
To overcome these problems, we used serial dilutions of DNA and PCR amplification to determine the frequencies of de novo gene conversions and deletions of CYP21 in sperm and leukocyte DNA from normal individuals. We found that deletions occur only during meiosis, whereas gene conversions occur at a considerably higher frequency and mainly during mitosis. (3) . Gene-specific positions in each sequence are underlined; the backslash in the sequence of oligonucleotide 1 denotes the position of a 2-nt insertion in CYP21P. these digests were analyzed by genomic blot hybridization to document DNA quality and to ensure that no subject carried a heterozygous deletion of CYP21 or a homozygous deletion of CYP21P.
MATERIALS
Detection of Gene Conversion Events. A two-stage heminested PCR amplification strategy was used, similar to the method described for detection of hybrid T-cell receptor genes (11) . Serial dilutions of each DNA sample were made ranging from 500 ng to 1 pg. All amplifications employed either manual or Ampliwax (Perkin-Elmer) "hot start" protocols and had an initial denaturation step of 94°C for 3 min and a final extension step of 72°C for 10 min. First amplifications used primers 1 and 2 (Table 1) and were run for 35 cycles of 94°C for 30 sec, 54°C for 30 sec, and 72°C for 1 min. Reaction products were loaded on 2% agarose gels and were visualized by staining with ethidium bromide. A 104 dilution from each first amplification was used for the second PCR round. Second amplifications used primers 1 and 3, primer 1 being end-labeled with [y-32P]ATP, and were run for 20 cycles of 94°C for 30 sec, 57°C for 30 sec, and 72°C for 60 sec. Reaction products were loaded on 8% polyacrylamide sequencing gels and were visualized by autoradiography.
Additionally, products of the first-stage PCR were directly subcloned into the pCR1000 vector (Invitrogen). Approximately 104 independent colonies from each subject were screened by hybridization in duplicate with a radiolabeled oligonucleotide probe (no. 4 Detection of De Novo Deletions. A two-stage PCR protocol similar to that described above was used. Serial dilutions ranged from 1 ,tg to 1 pg. First amplifications used primers 5 and 6 ( Table 1 ) and consisted of 35 cycles of 94°C for 1 min, 60°C for 1.5 min, and 72°C for 2 min. Second amplifications used primers 5 and 7 and consisted of 35 cycles of 94°C for 1 min, 66°C for 1.5 min, and 72°C for 2 min. Products of the second amplification were run on agarose gels, transferred to nylon membranes, and hybridized with a CYP21-specific internal oligonucleotide probe (no. 8, Table 1 ). Products of positive reactions were cloned into pCR1000 and individual clones were sequenced to confirm the location of the breakpoints.
RESULTS

Detection of De Novo Gene Conversion Events in Blood and
Sperm Samples. The most common mutation causing classic 21-hydroxylase deficiency, occurring in -25% of all affected alleles (7, 12) , is a A --G mutation in intron 2 ("i2g") at nt 656, 13 bp before the end of the intron. This mutation affects splicing of pre-mRNA (13) . We used a two-stage hemi-nested PCR strategy to detect this mutation occurring de novo in sperm or leukocyte DNA from five normal individuals. In the first PCR, a 156-bp segment of CYP21 was amplified by using gene-specific primers in intron 2 and exon 3. Molecules carrying i2g were then detected by allele-specific PCR using the same sense primer and an antisense primer complementary to i2g at its 3' end ( Fig. 1) .
To determine the sensitivity and specificity of this procedure, serial dilutions from 500 ng to 1 pg were made from a DNA sample from an individual known to be a heterozygous carrier of the i2g mutation. A positive signal was obtained at 1 pg (Fig. 2) . As this quantity of DNA is considered to correspond to one haploid genome, it suggests that the technique has nearly single-molecule sensitivity. A water control showed no amplification. As a more robust negative control, serial dilutions were made of a DNA sample from an individual who was homozygous for the HLA haplotypeAl;B8;DR3. This haplotype, which occurs on -5% of normal chromosomes, invariably carries a complete deletion of CYP21P (5, 14) and so this sample should not contain de novo recombinations between CYP21 and CYP21P. As expected, no such recombinations were observed. To rule out the possibility of in vitro recombinations being generated during the PCR, 500 ng of this negative control sample was spiked with 30 pg of a cosmid clone carrying CYP21P (-2 x 106 copies, representing an -4:1 ratio of CYP21P to CYP21 in each reaction), and serial dilutions were made. Again, no amplification was detected in the second, allele-specific PCR.
In contrast, de novo i2g mutations were observed in both sperm and leukocyte DNA from all five normal individuals (Fig. 3 ). Because these mutations were not observed in the individual who lacked CYP21P, they were presumed to be the result of gene conversion. The frequencies at which these recombinations occurred varied over 2 orders of magnitude among individuals; the lowest amount of DNA at which these mutations could be detected ranged from 1 to 100 ng. These DNA quantities correspond to mutation frequencies of 1 (Fig. 4) . In the first PCR, a CYP21P-specific primer in intron 2 and a nonspecific primer in exon 3 were used to amplify CYP21P as well as any CYP21P/CYP21 chimeric molecules that were present. This first step increased the sensitivity of the procedure and ensured that all DNA samples were amplified equally well. The second PCR included the same CYP21P-specific primer in intron 2 and a nested CYP21-specific primer in exon 3, thus amplifying only chimeric molecules. Serial dilutions of leukocyte and sperm DNA samples were tested.
Chimeric CYP21P/CYP21 genes with deletion breakpoints in the intron 2-exon 3 region were reproducibly detected in sperm DNA samples from three of the five individuals studied (Fig. 5) . Two individuals had positive signals when 100 ng of DNA was included in the reaction, whereas one subject had a positive signal only with 1000 ng of DNA. These results are consistent with frequencies of de novo deletions of 1 in 105_106 in these individuals; the remaining two subjects apparently have deletion frequencies of <1 in 106. These differ- . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  . . . . . . . . . . . . . . . 2 and an antisense primer located in exon 3 that could recognize either CYP21 or CYP21P (P6). The products of the first amplification are a segment of CYP21P and chimeric CYP21P/ CYP21 segments. A 104 dilution of the first PCR is used as a template for the second PCR, in which only chimeric genes are amplified by using the same CYP21P-specific sense primer (P5) and a CYP21-specific nested primer (P7) located in exon three. ences in recombination frequency are unlikely to be due to inter-or intraassay variability, since similar results were obtained with a second set of semen samples obtained from the same individuals (data not shown).
De novo deletions were not detected in leukocyte DNA from any individual, even though CYP21P sequences could be amplified from 1 pg (nominally one haploid genome) of these DNA samples (data not shown). Thus, unequal crossing-over events were detected only in DNA from cells that had undergone meiosis.
PCR products from positive sperm samples were cloned and sequenced. Twenty-four independent clones were analyzed; the deletion breakpoints were rather evenly distributed over the amplified region (Fig. 6 ).
DISCUSSION
Genetic recombination in higher eukaryotes is essential for maximizing genetic diversity among individuals and also for such important biological processes as development of immunoglobulin and T-cell receptor repertoires. Although recombination in immunoglobulin genes is relatively well understood, many questions remain about other forms of recombination, including whether there are specific sequences that promote or inhibit recombination (15) , specific chromosomal regions in which various types of recombination are more or less likely to occur (16) , and specific protein factors that are required for recombination. These questions are difficult to address by studying recombination in mammalian progeny, because of the small numbers of offspring available and the time and expense required to ascertain recombinant offspring. The direct study of meiotic recombination in spermatozoa is attractive because millions of meioses can be examined in a single semen sample. Previous studies have detected meiotic recombinations by assaying (3-galactosidase activity in sperm from transgenic mice (17) and by using PCR to type flow-sorted single spermatozoa for alleles at several linked loci (18) . With methods analogous to those employed in the present study, mitotic recombinations have been detected in T-cell re- Detection of de novo crossover events in sperm samples from healthy donors. Serial dilutions of DNA from matching blood and sperm samples from five healthy donors were amplified according to the procedure described in Fig. 4 . The amount of DNA in each dilution is noted in picograms. The first row shows ethidium bromide staining of the PCR products from the first amplification of the five sperm samples (the first amplification of the blood samples, which gave very similar results, is not shown; note that photographic negatives of the ethidium bromide fluorescence were used in this figure) . The second and third rows show the second amplifications of the five sperm samples and the corresponding blood samples, respectively. These products were hybridized with a radiolabeled CYP21-specific oligonucleotide (P8, Table 1 ) that should detect only CYP21P/CYP21 chimeric products in this experiment. Such products were observed only in sperm samples.
("VDf3i D Medical Sciences: Tusie'-Luna and White ceptor genes (11) , and meiotic recombinations have been detected in murine H-2 class II genes (19) and human minisatellites (20) .
CYP21 and CYP21P represent an interesting experimental system for studying recombination in humans. Due to the long tandem duplication in which these genes are located, diseasecausing mutations due to intergenic recombinations are relatively frequent and different types of recombinations (i.e., deletions and gene conversions) occur in the same genetic region. We confirmed that the deletions observed in these genes were generated by unequal meiotic crossing-over. Gene conversions, however, take place at equal frequencies in somatic cells (24, 25) and have only slightly lower sequence identity (95% vs. 98%) (26) . These genes are known to undergo unequal crossing-over, and the resulting duplication causes an autosomal dominant form of hypertension, glucocorticoid-suppressible hyperaldosteronism (24, 25) . Because both CYPJJBJ and CYP1IB2 encode active enzymes, gene conversions are difficult to ascertain in individuals but should be readily detectable by the approach used in the present study.
Finally, the existence of reproducible individual differences in recombination frequency is intriguing and needs to be confirmed in a larger number of subjects. In particular, one individual in our study had a high frequency of de novo gene conversion and a low frequency of deletions, suggesting that different factors may influence these two types of recombination. Individual differences could be due to nongenetic factors, polymorphisms linked to CYP21 and CYP21P, or genetic factors remote from CYP21. Of nongenetic factors, the most obvious is donor age, but our donors' ages varied within only a 13-year range, and frequencies of neither type of recombination were well correlated with age. Exposure of agricultural workers to environmental toxins increases somatic recombination in T-cell receptor genes (27) , but none of our subjects had any known exposure of this type. As regards polymorphisms linked to CYP21, it has been suggested that deletions of CYP21P, which occur on -5% of normal chromosomes, may predispose the trans chromosome to unequal crossing-over and deletion (28) . Consistent with this hypothesis, one individual in this study (subject 1) with a high rate of de novo unequal crossing-over indeed carried a deletion of CYP21P. Other flanking polymorphisms may also be involved, as even single nucleotide changes are known to influence gene conversion rates at human minisatellites (15) . If, instead, further studies suggest that factors remote from CYP21 influence either type of recombination, a panel of brother pairs in which deletion and gene conversion frequencies are known could be used to test candidate loci for their effects on these processes.
